Related Experiment Video
Updated: Jun 23, 2026

Characterization of Molecular Mechanisms of In vivo UVR Induced Cataract
Published on: November 28, 2012
Advances in pharmacological strategies for the prevention of cataract development
S K Gupta1, V Kalai Selvan, S S Agrawal
1Delhi Institute of Pharmaceutical Sciences and Research, Sector 3, Pushp Vihar, New Delhi-110 017, India. skgup@hotmail.com
Abstract:
Cataractous-opacification of the lens is one of the leading causes of blindness in India. The situation can be managed by surgical removal of the cataractous lens. Various pharmacological strategies have been proposed for the prevention and treatment of cataract. Information on possible benefits of putative anticataract agents comes from a variety of approaches, ranging from laboratory experiments, both in vitro and in vivo , to epidemiological studies in patients. This review deals with the various mechanisms, and possible pharmacological interventions for the prevention of cataract. The article also reviews research on potential anticataractous agents, including aldose reductase inhibitors, glutathione boosters, antiglycating agents, vitamins and various drugs from indigenous sources.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacogenomics: Identification of New Drug Targets
Ophthalmic Drug Delivery Systems
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Angle Closure Glaucoma: Treatment
Glaucoma: Overview